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Abstract
Background: South Asia is a hotspot for antimicrobial resistance due largely to over-the-counter antibiotic sales for
humans and animals and from a lack of policy compliance among healthcare providers. Additionally, there is high
population density and high infectious disease burden. This paper describes the development of social and
behavioural change communication (SBCC) to increase the appropriate use of antibiotics.
Methods: We used formative research to explore contextual drivers of antibiotic sales, purchase, consumption/use
and promotion among four groups: 1) households, 2) drug shop staff, 3) registered physicians and 4)
pharmaceutical companies/medical sales representatives. We used formative research findings and an intervention
design workshop with stakeholders to select target behaviours, prioritise audiences and develop SBCC messages, in
consultation with a creative agency, and through pilots and feedback. The behaviour change wheel was used to
summarise findings.
Results: Workshop participants identified behaviours considered amenable to change for all four groups.
Household members and drug shop staff were prioritised as target audiences, both of which could be reached at
drug shops. Among household members, there were two behaviours to change: suboptimal health seeking and
ceasing antibiotic courses early. Thus, SBCC target behaviours included: seek registered physician consultations; ask
whether the medicine provided is an antibiotic; ask for instructions on use and timing. Among drug shop staff,
important antibiotic dispensing practices needed to change. SBCC target behaviours included: asking customers for
prescriptions, referring them to registered physicians and increasing customer awareness by instructing that they
were receiving antibiotics to take as a full course.
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Conclusions: We prioritised drug shops for intervention delivery to all drug shop staff and their customers to
improve antibiotic stewardship. Knowledge deficits among these groups were notable and considered amenable to
change using a SBCC intervention addressing improved health seeking behaviours, improved health literacy on
antibiotic use, and provision of information on policy governing shops. Further intervention refinement should
consider using participatory methods and address the impact on profit and livelihoods for drug shop staff for
optimal compliance.
Keywords: Intervention, Antibiotic stewardship, Bangladesh, Antibiotic resistance
Background
South and South East Asia are hotspots for antimicrobial
resistance (AMR) [1] and newly evolved AMR organisms
from other regions have spread rapidly across the world
[2]. Contributing factors include availability of cheap,
locally manufactured over-the-counter antibiotics for
humans and animals, a lack of compliance with stan-
dards among healthcare providers, weak regulatory sys-
tem, and high population density [3] (WHO, 2015).
While per capita antibiotic consumption rates in low-
and middle-income countries (LMICs) have been lower
than those in high income countries, these are increasing
dramatically in line with increases in gross domestic
product [4]. Human antibiotic consumption rates are
predicted to increase globally by 200% from 2015 to
2030 [5]. In South Asia, dispensing antibiotics without a
prescription is common [6–8]. Community members
and healthcare providers’ understanding of antibiotics
and their mode of action is limited [9, 10].
In Bangladesh, community members access antibiotics
for themselves and their animals through a healthcare
system that is pluralistic and less institution-based than
elsewhere [11, 12]. Unqualified healthcare providers are
a major source of health care for the poor and disadvan-
taged [13, 14]. These providers can include drug shop
staff that have no recognised qualification. It is estimated
that Bangladesh has 200,000 retail drug shops and ap-
proximately 50% of those are unlicensed [15]. While lit-
tle is known about quantities of antibiotics dispensed
through the various channels in the healthcare system, a
recent study reported that 29% of the antibiotic prescrip-
tions came from qualified doctors and 63% from un-
qualified healthcare providers [16]. Recent studies
conducted by our group suggest that there is a consider-
able volume of antibiotics dispensed without a prescrip-
tion, often by unqualified providers [17]. Antibiotics
administered by these groups are shorter courses and
not appropriate for the illness [18], which can contribute
to AMR.
From the supply-side, previous studies on antibiotic
dispensing in Bangladesh have reported polypharmacy,
detected among 25% of prescriptions from rural hos-
pital outpatient clinic doctors [16]. Overprescribing,
using unnecessarily expensive drugs and dispensing
drugs without a prescription is common [15, 19].
Additionally, drug sellers and healthcare providers are
exposed to aggressive marketing strategies, especially
through pharmaceutical company representatives [20].
From the demand side, limited data are available on
household-level antibiotic use for humans and their
animals/livestock [16, 21].
Bangladesh has taken steps to address poor compli-
ance with accepted standards for antibiotic prescription
with the launch of the Bangladesh Pharmacy Model
Initiative (BPMI) for all medication categories in 2016,
which also forms a key part of the national action plan
on AMR. It includes standards for drug outlet personnel,
premises, dispensing, storage, hygiene, record keeping,
disposal and allowable products. To date there have
been 193 model pharmacies and 154 model medicine
shops developed [22, 23]. The BPMI requires retail out-
lets to provide medications only to customers with a
prescription, dispensed by staff with pharmacy qualifica-
tions and training [24]. The National Drug Policy, 2016
[25] provides the legal requirements for drug dispensing:
it “prohibits sales and distribution of drugs without pre-
scription from registered physician to ensure rational
use of drugs” and “Retail sales of drugs is prohibited
without prescription by registered physicians/ veterinar-
ians other than the over-the-counter drugs”.
Antibiotic stewardship programmes, to optimise anti-
biotic dispensing and consumption, have predominantly
been implemented in high income countries and in hos-
pitals [26]. A review of programmes/interventions to re-
duce antibiotic prescribing in LMICs reported that the
majority (n = 36) took place in hospitals and 9 in phar-
macies, with mixed success [27]. In the review, the
authors noted that few stewardship interventions
included more than one healthcare provider group or
setting [27]. In Tanzania, a programme to improve anti-
biotic stewardship targeted drug shops as part of
accreditation in as many as 9000 premises which
included training staff in appropriate antibiotic dispens-
ing [28]. Ten years after the programme began, audit
studies have detected residual needless antibiotic dis-
pensing among one-third of the shops [29].
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Understanding the behaviours, service and economic
priorities of healthcare providers, and the needs of con-
sumers is therefore central to developing an effective
strategy to engage in antimicrobial stewardship to re-
duce antibiotic resistance [17, 30]. This study is part of a
larger project that aimed to inform government policy
and identify pathways to behaviour change among
groups from the antibiotic supply and demand sides
[31]. The specific objective of this paper is to describe
the development of social and behavioural change com-
munication (SBCC) messages aimed to increase the ap-
propriate use of antibiotics. We explored antibiotic sales,
purchase, use/consumption and promotion to identify
contextual drivers among four groups: 1) households, 2)
drug shop staff, 3) registered physicians and 4) pharma-
ceutical companies/medical representatives. We used
formative study findings from this research in conjunc-
tion with outcomes from an intervention design work-
shop with stakeholder to identify target behaviours, and
in consultation with a creative agency, to prioritise audi-
ences and refine SBCC messages.
Methods
In this study we collected data for integration into the
first four steps of the behaviour change wheel, used to
formulate behaviour change interventions [32, 33].
These steps include 1) defining the problem in behav-
ioural terms, identifying who performs the behaviours
and listing all other behaviours that might influence the
problem behaviour; 2) selecting the target behaviour, 3)
specifying the target behaviour, and 4) identifying what
needs to change [33].
Formative data collection provided information for
step 1 [17, 30] on current key behaviours. Following the
formative research, steps 2 to 4 were undertaken
through an intervention design workshop and the co-
creation of intervention resources with a creative agency.
Formative study
The objectives of the formative study were to a) deter-
mine the drivers of household decision making on
healthcare consultations and antibiotic purchase and
consumption; b) determine the practices among regis-
tered and unqualified healthcare providers (doctors, drug
shops); and examine the interactions of drug shops and
doctors with pharmaceutical company representatives.
We selected one rural community in Tangail district and
one urban community in Gazipur district. The sites were
selected where households had access to a range of drug
shops and health care facilities.
Formative respondent selection, data collection and
data analysis details have been described previously
[17, 31]. In brief, between May 2017 to January 2018
data were collected through face-to-face and in-depth
interviews with groups that were identified as key
actors in community-level antibiotic dispensing, use,
consumption and promotion based on review of exist-
ing literature. The key actors for data collection com-
prised household members (n = 48); drug shop staff
who were either unqualified (n = 13) or had up to 12
months training (n = 14); registered physicians in hu-
man and veterinary medicine (n = 12); auxiliary
healthcare providers (n = 7) and key informants in-
cluding pharmaceutical company representatives and
non-government organisations (e.g., Bangladesh Drug-
gist and Chemist Association) (n = 13). Respondents
were selected to comprise as diverse a group as pos-
sible and thus provide a wide range of responses,
based on qualitative research principles. Interviews
were audio-recorded and transcribed in Bangla. A
third of all transcripts were translated in full into
English by native Bangla-speaking researchers. The
remaining Bangla transcripts were coded in Bangla,
and then translated into English and shared with the
research team.
Intervention design workshop
The objective of the workshop was to obtain stakeholder
expert input in the selection of key behaviours and audi-
ences for an intervention. In conjunction with a local
creative agency, Visual Communications Ltd. (VISCOM,
https://www.viscombd.com), we invited 60 people to
participate in a 1 day workshop in February, 2018 in-
cluding stakeholders to potentially cover all that likely
have a stake in reducing AMR such as from the Govern-
ment Directorate General of Health Services, Directorate
General of Drug Administration and the Department of
Livestock Services; pharmaceutical industry and medical
representatives; the Bangladesh Chemist and Druggist
Association, local non-governmental organisations
(NGOs), drug shop owners, implementing partners, and
the research team; 33 attended.
We shared emerging findings from the formative stud-
ies with the workshop participants relating to healthcare
seeking behaviours and antibiotic supply, dispensing and
consumption. Based on research findings and input from
the workshop participants the study team, in association
with the design agency, discussed different specific con-
tent, target audiences and behaviour options. Workshop
attendees participated in group work focusing on each
of the four possible target audiences (householders, drug
shop staff, registered physicians, pharmaceutical com-
panies/medical representatives) to a) define the problem
in behavioural terms (who performs behaviours, other
behaviours that might influence the problem behaviour);
b) select target behaviour, specifying target behaviour,
identify what needs to change and c) propose SBCC
messages. Each group had a facilitator from the research
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team and a rapporteur who recorded discussions on
template Powerpoint slides which were presented to
workshop participants. Suggestions provided during the
group work feedback session were recorded. The work-
shop concluded with a voting exercise where each
attendee was provided with stickers to vote for their first
and second priority among the four groups/ target
audiences.
Working with a creative agency to develop key messages
in collaboration with the research team
VISCOM collaborated with the research team to collate
the suggested target behaviours we wished to change
and supporting messages from the workshops. Draft
intervention resources were designed in English and
Bangla and the research team provided feedback. Further
feedback was obtained through a display session in the
Environmental Interventions Unit at the International
Centre for Diarrhoeal Disease Research, Bangladesh
(icddr,b) to solicit suggestions from experienced re-
searchers who have worked on a wide range of SBCC
interventions.
After incorporating initial feedback, intervention re-
sources were piloted in two convenience sample selected
drug shops each from one rural and one urban setting
(total 4) in July 2018. Interviews with one drug shop staff
and one customer per drug shop were used to explore
understanding of messages and anticipated impact of the
intervention resources on behaviour. This feedback was
used to revise intervention materials. Revised interven-
tion resources were subsequently distributed to 95 con-
venience sample selected drug shops in September 2018
from the same two geographic areas and remained for a
month. From the 95 pharmacies, 50 were randomly se-
lected and interviews conducted with one drug shop
staff and one customer from each drug shop 1 month
after intervention resource delivery. Interviews followed
an open-ended questionnaire similar to that used in the
earlier pilot among 4 shops, collected demographic in-
formation, and sought suggested further changes on ap-
pearance or content.
Data analysis
Data collected from formative studies were analysed
using framework analysis, as described previously [17].
In addition to guiding data collection, data were mapped
using the behaviour change wheel [32] for steps 1 to 4,
as described by Munir et al. [33]; these are mapped
against study components in Fig. 1. For steps 1–3, data
analysed from formative studies and data collected dur-
ing the workshop were summarised (Table 1). For step
4, for the prioritised audiences, we used the Capability,
Opportunities, Motivation-Behaviour (Com-B) frame-
work [32] to summarise data to provide detail on the
behaviours that need to change (Table 2).
Results
Defining the problem in behavioural terms among four
groups from formative studies (step 1)
Contextual drivers of antibiotic use among house-
hold members, and the inappropriate prescribing and
dispensing practices of healthcare professionals and
drug shop staff have been published [17, 30]. Among
household members, an important contextual driver
Fig. 1 Schematic of study components
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Table 1 Behaviour change and intervention components for the four groups from the intervention design workshop
Behaviours Proposed intervention messages**
Current practice/contextual drivers* Selected behaviours to change
Households
• Don’t know what an antibiotic is
• Don’t know what an antibiotic is for
• Drug shops common first point for health
advice
• Purchase drug without prescription/ without
doctor’s advice; sometimes ask for antibiotics by
name
• Underage purchaser and proxy for patient
• Use peer group prescribed antibiotic
• Antibiotics are stopped when symptoms
disappear or if patients consider that they don’t
work
• Don’t reuse drugs for subsequent illnesses
• Have high level knowledge of medicine expiry
• Consult registered physicians or health
workers
• Ask the healthcare provider if they have been
given antibiotics and why
• Buy full course of antibiotic and continue
according to the prescription
• Ask about dose frequency and duration/
instruction on use
• Choose a pharmacy that maintains quality
drugs
• Consult with registered physician for
prescription; (who are they and how do
patients know if doctor is registered)
• Buy full course of drugs and complete the
course; Follow your prescription to recover
• If you don’t follow instructions, it will cost you
more ultimately
• If you suffer from any adverse effects, consult
your doctor immediately
• Buy medicines from reputable company
Drug shops
• Most common source of medical advice; minor
illness
• Dispensing without government license
• Unqualified staff dispensing antibiotics, with
short (6 weeks) or no training
• Dispense antibiotic without seeing the patient/
animal, prescribe over phone
• Follow elite doctor prescriptions when asked
for advice
• Do not always give a name to the type of
illness
• Often advise and sell drugs for livestock
• Some drug sellers know antibiotic generation
no.
• Few drug sellers are familiar with antibiotic
resistance”
• No clear idea on consumer rights
• Ask for prescription before dispensing
antibiotics
• Refer customers to registered physicians
• Increase awareness among patients; tell
purchasers which is an antibiotic- stress
importance of taking full course
• Recruit qualified staff
• Do not change the medicine when
prescribed by a registered physician
• Stop selling antibiotic without registered
doctor’s prescription
• Tell customer that you are providing an
antibiotic
• Dispense full antibiotic course and give
instructions for consumption
• Unnecessary antibiotic use is harmful
• Check expiry date before dispensing drugs
Registered physicians
• See patients with more severe disease
• Give little time during consultation
• Prescribe over telephone
• Overprescribe antibiotics and provide
unnecessary tests, to make profit
• Prescribe to keep patients happy
• Prescribe poor quality antibiotics
• Follow prescriptions of senior/renowned
doctors
• Limited knowledge of antibiotic generations
• Don’t request tests before prescribing
antibiotics/prescribe for viral infections
• Don’t counsel on antibiotic use or the
consequences of overuse
• Not up to date on current literature
• Take incentives from pharmaceutical companies
• Motivated by medical representatives to
prescribe antibiotics
• Do not provide antibiotic prescription when
not necessary; consult recent
recommendation information
• Resist prescribing later generation antibiotics
• Reinforce that the full course is important to
complete
• Prescribe only when the patient presents at
the consultation
• Follow knowledge and practice on up to date
information on antibiotic resistance
• Do not provide antibiotic prescription when
not necessary
• Provide instructions for consumption, include
the need for a full course
Pharmaceutical companies/medical representatives
• Have regional offices and numerous staff for
product promotion and distribution
• Are aware of government policy
• Have thorough understanding of antibiotic
resistance
• Purported provision of incentives to doctors to
prescribe, drug shop staff to sell
• Range of product quality
• Representatives have monthly visit quotas for
doctors to promote products, distribute sample
Companies
• Modify business strategy
• Deliver quality training
• Package antibiotics according to course
• Include warning messages on packet
Medical representatives
• Motivate the drug seller to sell full courses of
antibiotic
• Don’t review prescriptions at doctors’ offices,
drug shops
• Promote full courses of antibiotic for better
health
• Ensure the proper use of antibiotics
• Ensure profit, protect yourself and others
• Do quality business for community health
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was that most did not what know an antibiotic was
or what antibiotics were for. Household members
and healthcare providers reported that antibiotics
were stopped when symptoms disappeared. Antibi-
otics were often purchased by proxies for ill house-
hold members/patients. Underage children and
adolescents were also able to purchase antibiotics
from drug shops. Drug shop staff, regardless of
training and qualification, in addition to dispensing
antibiotics prescribed by registered physicians, dis-
pensed antibiotics as over-the-counter medications.
Counter to common assumptions, households did
not report storing or re-using old antibiotics.
A contextual driver of antibiotic dispensing among drug
shop staff was that they regularly sold prescription drugs
including antibiotics without a government license, in
conflict with government policy. Drug shop staff advised
and dispensed drugs to patients and their proxies, who
were usually family members. Unqualified drug shop staff
reported that they followed antibiotic prescribing patterns
of registered physicians, referred to as ‘elite’ doctors/‘boro
(big)’ doctors.
Table 1 Behaviour change and intervention components for the four groups from the intervention design workshop (Continued)
Behaviours Proposed intervention messages**
Current practice/contextual drivers* Selected behaviours to change
medicines to physicians
• Provide products to drug shops sometimes on
credit, some with incentives (e.g. one free box)
• Review prescriptions for marketing strategy
• Don’t motivate patients to purchase drugs in
front of doctor’s offices, drug shops
*data from formative studies; **data from workshop working groups
Table 2 Using the Com-B model to inform households/customer and drug shop staff intervention to improve antibiotic
stewardship
Behaviour to change Capability Opportunity Motivation
Households
Suboptimal health seeking
• Purchase drugs without prescription; sometimes
ask for antibiotics by name since unqualified
healthcare providers first point for health
• Use peer group prescribed antibiotic
Psychological





• Accessibility, cost, symptom
severity drive health seeking
behaviour
Physical
• Easy access to (free) health
advice from drug shop staff
Physical
• Need information on who and where
are registered physicians
• Registered physician/population is low
Social
• Males are decision makers on
expenditure, visit drug shop












• When symptoms disappear
• When patients consider that they don’t work
Psychological
• Don’t know what an
antibiotic is/ its use
• Limited understanding of
how antibiotics work
Physical
• Full course not purchased
Physical
• Need information about the
importance of why drug is prescribed
• Need information on dosage and
timing, need for full course
• Cost barrier to full course
Social
• Social norm to stop medications when
disease is ‘cured’
Reflective








• Without government licensea
• Without prescription from registered physicianb
• Without seeing the patient/animal, prescribe
over phone
• By unqualified staff/ with short (6 weeks) or no
traininga
• Follow elite doctor prescriptions when asked for
advice
• Do not always give dosing instructionsa
• Not familiar with antibiotic resistance
Psychological
• Limited knowledge of the
policies, rules and penalties




• Educate drug sellers on antibiotic
resistance
• Address financial implications on their
businesses
• Intervention can replace medical
representatives as a source of trusted,
unbiased information on antibiotics
• Policy is specific about staff
qualification
Reflective






aas outlined in the Bangladesh Model Pharmacy initiative [24]; bas outlined in the Bangladesh National Drug Policy, 2016
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Patients were more likely to consult registered physi-
cians for more severe diseases, or after an initial treat-
ment had failed. Travel costs and distance to health
facilities or clinics were barriers to seeking earlier con-
sultation with qualified professionals [17]. However, doc-
tors were reported to give little time during
consultation, prescribe drugs including antibiotics over
the telephone and patients perceived that the additional
costs of consulting a doctor or undergoing recom-
mended tests were to enhance profits and were often
viewed as unnecessary [30].
Pharmaceutical companies were reported to provide
incentives to doctors for prescribing their company’s an-
tibiotics. In contrast with registered doctors and drug
shop staff, pharmaceutical representatives were fully
aware of the BPMI policy and had a thorough under-
standing of antibiotic resistance.
Selecting and specifying target key behaviours (steps 2
and 3)
Based on data from formative studies on contextual
drivers, participants in the intervention design workshop
selected and specified behaviours that were amenable to
change (Table 1).
Household members: should be encouraged to consult
registered physicians and be pro-active in obtaining in-
formation about dispensed medications such as whether
they are antibiotics. For those receiving antibiotics, the
dose, frequency and duration of the course should be ex-
plained. Patients/consumers should be encouraged to
take a full course of antibiotics obtained from a drug
shop that sells quality medicines.
Drug shop staff: should be encouraged to ask the cus-
tomer for a prescription before dispensing antibiotics;
referring them to doctors when they do not provide a
prescription. Drug shop staff were considered to have a
responsibility to increase awareness among patients, par-
ticularly on the importance of taking a full course of an-
tibiotics. Stakeholders thought that there should be
incentives for drug shops to recruit qualified staff.
Registered physicians: should be encouraged to base
practices on current recommendations to reduce un-
necessary prescribing, especially avoiding prescribing
multiple and higher generation antibiotics than is neces-
sary. Doctors were considered as important information
sources that should reinforce the importance of com-
pleting a full course of antibiotics.
Pharmaceutical companies/medical representatives:
Stakeholders acknowledged the potential for companies
and their representatives to maintain a viable business
whilst playing a role in antibiotic stewardship.
Suggestions included: modifications to the business
strategy of companies; delivering quality training to all
representatives and designing antibiotic packaging in a
way that would encourage sale of a full course.
Identifying priority audiences
Among 28 participants who voted for first and second
priority audiences to target, 19 voted for household
members, 12 of which considered this population as
their number one priority and 16 voted for drug shop
staff, 8 of which voted for this group as their first prior-
ity. Doctors were the third priority target audience with
13 votes and pharmaceutical companies/representatives
were the lowest priority with 8 votes. During the post-
workshop discussions, the research team and creative
agency members concluded that using drug shops as a
venue for intervention delivery had potential to address
both the first and second priority audiences, thereby
providing an opportunity to maximise intervention
impact.
Capability, opportunity and motivation to improve
antibiotic stewardship among priority audiences (com-B
model, step 4)
In line with government policy and guidelines [25, 34],
to improve antibiotic stewardship, the target behaviors
were to sell and purchase fewer antibiotics and to sell
and consume antibiotics as full courses only.
Among households, there were two main behaviours
that needed to change: suboptimal health seeking and
early cessation of antibiotic treatment. When assessing
capabilities, a recurring theme was knowledge. Most
household members could not distinguish a qualified
from an unqualified provider and made decisions on
who to visit primarily on disease severity considerations.
They also had limited knowledge about antibiotics and
their mode of action. Thus, opportunities exist for devel-
oping an SBCC that strengthens knowledge that can em-
power household members with potential to impact
responsible antibiotic consumption. These include en-
couraging household members to ask about the medi-
cines that they receive, and ask about timing, dosage,
and course duration. Motivation for this group can be
encouraging them to seek appropriate healthcare advice
and medicines by appealing to potential financial burden
and accessibility to registered physicians.
When identifying drug shop staff behaviours that
needed to change, there were similar capability issues
evident as limited knowledge of the government policy
including the BPMI on licensing, staff qualification and
adequate provision of information on antibiotics to cus-
tomers. They lacked knowledge about antibiotic resist-
ance. Some of these knowledge gaps can be filled using
an educational SBCC. Drug shop staff are likely to re-
main the first line of access to health care in many com-
munities, presenting an opportunity to have them serve
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as an information source on antibiotic use/dose/timing
for customers. For an educational campaign that is lo-
cated at drug shops, it must motivate drug shop staff by
addressing financial concerns of potential lost business
by encouraging household members to seek care from
registered physicians and by acknowledging their status
in the community. While the BPMI is clear about staff
qualifications, there does not appear to be evidence of
enforcement, which could act as a motivator (Table 2).
Intervention resource development and pilots for
household members and drug shop staff
The National Drug Policy, 2016 states ‘To prohibit sales
and distribution of drugs without prescription from reg-
istered physician to ensure rational use of drugs”. During
the pilot phase of intervention resource development,
there was considerable discussion on how to convey
‘registered physician’. Household members often referred
to their local drug shop staff as a doctor or ‘small doctor’
[17]. Village doctor is also a common term used for a
rural health practitioner, a post that is not considered a
registered physician. To overcome existing ambiguity,
we decided to pilot ‘(Bachelor of Medicine, Bachelor of
Surgery) MBBS doctor’ for the intervention resources
and measure understanding of this term among drug
shop staff and customers.
Among the messages suggested during the interven-
tion design workshop, the research team and VISCOM
team prioritised those that we thought would resonate
with the two selected audiences. For drug shop staff,
these were related to asking for prescriptions, referral to
registered physicians, increase in client/customer aware-
ness when they were receiving an antibiotic, and the
need for a full course.
Pilot feedback
Pilot drug shop staff respondents were all male, between
20 and 62 years of age and education status ranged from
Secondary School Certificate (approximately grade 10)
to master’s degree, with most having a Higher School
Certificate (approximately grade 12) qualification. All 50
respondents received and displayed the intervention ma-
terials and found them simple, clear and easy to read.
Among the recommendations on antibiotics, 5 thought
they would be difficult, 5 thought they would need time
to integrate recommendations and the remainder
thought the recommended behaviours were reasonable.
There were suggestions on format (color, number of
messages and font size).
Among the customers, 40 were male, 10 were female,
ranging in age from 20 to 65 years. Some had no educa-
tion, and most had attended between grade 5 and
Higher School Certificate with one completing a mas-
ter’s degree. The vast majority (45) found that the
messages were simple and easy to understand and were
able to repeat the key messages. However, they found
recommendations were different from their usual prac-
tices reporting that they buy antibiotics directly as it is
easier and saves money and they didn’t see a justification
for visiting a registered physician for simple diseases.
The majority (40) reported that medicines were recom-
mended to them by the drug shop staff. Similar to drug
shop staff materials, customers recommended some for-
mat revisions such as using more color, including fewer
messages and using a larger font.
Revised intervention resources included the following
messages (example in Fig. 2), for drug shop staff: tell the
customer when you sell them antibiotics, remind them
of timing and completing the full course, always sell an-
tibiotics prescribed by a doctor (MBBS), refer patients to
doctors for the appropriate treatment, tell customers to
report side effects to doctors. For customers messages
included: antibiotics cure illness by killing germs, take a
full course and follow dose and timing to be cured, not
taking a full course may cause your disease to return
and cost more money, antibiotics are not needed for all
diseases, only a MBBS doctor can prescribe antibiotics.
Discussion
Among the four groups examined, each contributed to
poor antibiotic stewardship. Drivers of over-the-counter
antibiotic dispensing came from the demand side, such
as customers sometimes asking for specific antibiotics
and from the supply side where important influences in-
cluded product promotion by pharmaceutical company
representatives.
Most antibiotic stewardship programmes have
centered around institutional settings where more con-
trol can be exerted [27]. However, in Bangladesh and
other LMICs, institution prescriptions for antibiotics
likely constitute a small proportion of those consumed
[16–18]. Based on expert input from stakeholders, for an
intervention to address antibiotic stewardship in
Bangladesh, the two priority audiences were household
members (customers) and drug shop staff; delivering an
intervention at drug shops can reach both audiences. In
Bangladesh and other LMICs, drug shops are the first
point of healthcare contact [35].
A barrier to encourage community members to obtain
a prescription is an inability to convey ‘registered physi-
cians’, the term used in the National Drug Policy, 2016
[25] in simple terms, largely due to the community’s in-
ability to distinguish between the various labels of ‘doc-
tors’. There are many groups that are referred to as
some type of doctor in the absence of formal qualifica-
tion in both urban [11] and rural settings [12]. Despite
this, community members likely understand that their
local drug shop staff is not a fully qualified, practicing,
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medical practitioner that has completed medical school
training. Moreover, there is confusion over training
levels for people working in drug shops and almost no
knowledge among consumers on policy. While access
and cost remain important motivators to seek health
care and relevant medications from the local drug shop,
it seems impossible for drug shop staff and consumers
to adhere to the current policy. Further advocacy among
drug policy stakeholders to convey that several steps are
needed to bridge the vast gulf between obtaining medical
advice and antibiotics from drug shops (current practice)
and obtaining prescriptions from a registered physician
(policy targeted practice) is imperative for the country to
move towards improved antibiotic stewardship.
We detected poor knowledge of relevant policies, in-
cluding penalties for non-compliance, especially among
drug shop staff, who are those predominantly affected.
An international analysis found that poor governance
and poor community infrastructure were both associated
with higher AMR prevalence [36]. In Asia, rates of anti-
biotic dispensing without a prescription have changed
little over the last 30 years [37], suggesting weak regula-
tion. Thus, interventions that can improve policy know-
ledge and in turn can impact AMR should be considered
along with lobby and advocacy efforts with relevant
government agencies.
Policy on antibiotic prescribing needs to be consid-
ered along with the lack of an alternate route to med-
icines; restricting access to antibiotics purchased
through unlicensed drug shops will have a negative
effect on human health in communities where
infectious disease rates remain high [17]. Thus, our
expert group suggested that drug shop staff should be
included when addressing antibiotic stewardship, even
though government policy specifies that antibiotic
prescriptions are acceptable from ‘registered physi-
cians’ only. Access to registered physicians is not cur-
rently possible for large sectors of the population
because the number of registered physicians is insuffi-
cient to meet demand [38, 39]. Cost and convenience
are also important barriers for patients to seek care
from qualified physicians [17, 30], echoed in the find-
ings from piloting the SBCC intervention resources .
These challenges are similar in other settings with
over-the-counter provision of antibiotics [40, 41].
Drug shop staff have little incentive to comply with
government policy. Drug shop staff need motivation to
comply with licensing, the prescribing policy and mini-
mum staff qualification, all of which are beyond the
scope of an education based SBCC. The accredited drug
dispensing outlet (ADDO) programme from Africa in-
cludes business incentives [42] which have the potential
to offset perceived loss from compliance with a steward-
ship intervention.
Knowledge deficits were notable, and these are amend-
able to change using a SBCC intervention to improve
health seeking behaviours, improve health literacy on
antibiotic use and action and to inform drug shop staff
about legal requirements. Training based programmes
for drug shops have been conducted in Asia on dispens-
ing medications for specific illnesses, with mixed results
[37]. The ADDO programme that permits groups other
Fig. 2 Example intervention resource: Medicine pack*. * produced as a paper bag for customers to carry dispensed antibiotics and other
medicines, provided by drug retail shops – to raise awareness of when customers were receiving an antibiotic
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than registered physicians to prescribe and dispense an-
tibiotics may be a model that the Government of
Bangladesh could consider. The cadre of government
employed auxiliary healthcare providers (persons with
1–4 years of medical-related training) who are permitted
to prescribe a limited number of drugs, some of which
include antibiotics, could be further trained and mobi-
lised to meet needs that fall between registered physi-
cians and unqualified providers.
This study has several limitations. Respondent selec-
tion for data collection was based on convenience
sampling and therefore was likely not representative
of the population. Additionally, sites selected for for-
mative data collection and SBCC pilots unlikely repre-
sented all geographic and socioeconomic populations.
The data collection objective was to analyse as varied
responses as possible. We ensured that data were col-
lected from respondents from both urban and rural
settings, where characteristics such as distance from
healthcare facilities, population density and health
seeking behaviours likely differed. A strength of the
study was utilizing the behaviour change wheel as a
systematic framework for data synthesis. In this
study we describe data collection and synthesis to
complete steps 1–4 outlined by Munir et al. [33] of
the behaviour wheel [32] and the Com-B model for
intervention development. The remaining aspects of
step 5 and subsequent steps: identify behavioural
change techniques; use APEASE criteria to grade
these; identify mode of delivery, need to be explored
in future research. Further refinement of intervention
messages to improve antibiotic stewardship among
drug shop staff and their customers could benefit
from more interactive development such as using co-
design methods. Drug shop staff will be unable to
comply with an intervention that severely impacts
profit and their livelihoods and further exploration of
the economic aspects of an antibiotic stewardship
intervention, relevant to this context, is necessary.
This study focuses on intervention development for
two of the four groups explored, based on priorities
suggested by expert opinion. It may be necessary to
involve the remaining groups that may either have
greater affect or be easier to engage with on antibiotic
stewardship in the future.
Conclusions
This study drew on expert opinion and formative studies
to guide development of an SBCC with priorities audi-
ences; these need further collaboration with target audi-
ences to refine messages and delivery methods. The
study identified the likely poor penetration of relevant
policy and penalties. Policies had limitations of flexibility
to respond to the vast gap between current health
seeking and prescribing practices at drug shops com-
pared to recommendation of dispensing antibiotic only
against prescription from registered physicians. Research
that includes BPMI audit studies similar to those con-
ducted in Africa [28] will further aid collaborative and
advocacy efforts with relevant agencies in the Govern-
ment of Bangladesh to improve antibiotic stewardship.
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